BriefCase - Vessel Occlusion LVO & MeVO Triage

Aidoc
Aidoc's vessel occlusion algorithm is a triage algorithm that alerts clinicians to suspected vessel occlusion pathologies in both anterior and posterior circulations, including distal occlusions. (Specifically: Large Vessel Occlusion (LVO) - MCA-M1, PCA-P1, ACA-A1, ICA, Basilar; and Medium Vessel Occlusions (MeVO) - MCA-M2, MCA-proximal M3, PCA-P2, PCA-proximal P3, ACA-A2, ACA-proximal A3, and Vertebral-V4). This algorithm is run on head CT Angio images.
Information source: Vendor
Last updated: February 16, 2025

General Information

General
Product name BriefCase - Vessel Occlusion LVO & MeVO Triage
Company Aidoc
Subspeciality Neuro
Modality CT
Disease targeted Large Vessel Occlusion (LVO) - MCA-M1, PCA-P1, ACA-A1, ICA, Basilar; and Medium Vessel Occlusions (MeVO) - MCA-M2, MCA-proximal M3, PCA-P2, PCA-proximal P3, ACA-A2, ACA-proximal A3, and Vertebral-V4.
Key-features Vessel occlusion triage, prioritisation, notification
Suggested use Before: adapting worklist order,
Before: flagging acute findings,
During: perception aid (prompting all abnormalities/results/heatmaps)

Technical Specifications

Data characteristics
Population Adults or transitional adolescents aged 18 and older
Input Head CTA
Input format DICOM
Output Image review software, desktop application, alert notifications, worklist prioritisation
Output format Annotated images: DICOM Secondary Capture Worklist prioritisation: own application, HL7, API, bespoke integration
Technology
Integration Integration in standard reading environment (PACS), Integration RIS
Deployment Hybrid solution, Cloud based, Locally on dedicated hardware
Trigger for analysis Automatically, right after the image acquisition
Processing time 1 - 10 minutes

Regulatory

Certification
CE
Certified, Class IIa , MDR
FDA 510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE) A radiological computer aided triage and notification software indicated for use in the analysis of head CTA images in adults or transitional adolescents aged 18 and older. The device is intended to assist hospital networks and appropriately trained medical specialists in workflow triage by flagging and communication of suspected positive findings of complete Large Vessel Occlusion (LVO) - MCAM1, PCA-P1, ACA-A1, ICA, Basilar; and Medium Vessel Occlusions (MeVO) - MCA-M2, MCA-proximal M3, PCA-P2, PCA-proximal P3, ACA-A2, ACA-proximal A3, and Vertebral-V4.

Market

Market presence
On market since 09-2019
Distribution channels Change Healthcare, Merge Merative
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Subscription
Based on Number of analyses

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance

  • Abstract and Poster: Automated Detection of Intracranial Proximal Vessel Occlusion on Computed Tomography Angiography (read)
Other relevant papers

  • Introducing Artificial Intelligence Applications at Our Community Hospital: A Contrarian Approach (read)